Funding Imbalance: Government ka hi sabse bada hath?
Minister Dharmendra Pradhan ne ek badi problem highlight ki hai: India mein R&D ki funding ka 70% toh government hi de rahi hai. Yeh bahut hi "unhealthy sign" hai, unka kehna hai. Jabki China mein 77%, US mein 75%, aur South Korea mein 79% private sector funding karta hai. India ka total R&D spending GDP ka sirf 0.64% hai, jabki top countries 2.5%-5% tak kharch karte hain. Government ne private investment ko badhane ke liye ₹1 lakh crore ka corpus toh bana diya hai, par private sector ka direct R&D mein contribution sirf 36% ke aas paas hai. Jab government hi sab de, toh resources risky, breakthrough innovations ki jagah safe, incremental projects mein ja sakte hain.
Startup Boom Chalta Hai, Par Reality Kuch Aur Hai
Apna startup scene toh bhag hi raha hai, ab 2.5 lakh se bhi zyada ventures hain, aur Global Innovation Index mein bhi hum 38th place par aa gaye hain. Lekin asliyat kuch aur hai: lagbhag 90% startups paanch saal mein band ho jaate hain, aur 2025 mein toh 11,000 se zyada band hue! Research ko market tak pahunchane ka jo gap hai, wohi 'valley of death' hai. Kai startups ke patents sirf concepts hain, ready-to-sell products nahi. 2025 mein tough funding environment ne cash crunch badha diya, jisse early-stage failures badh gaye. Zyada growth ke chakkar mein profit ko bhul gaye, toh market correction ne unhe sabak sikha diya.
IIT Madras: Industry-Academia Ka Model
IIT Madras jaise institutions dikha rahe hain ki academic research ko industry se kaise jodna hai. Unke Research Park aur Incubation Cell se startups ko support milta hai aur technology transfer mein help hoti hai. Jaise Healthcare Technology Innovation Centre (HTIC) ne 12 successful medical devices launch kiye hain, ya Caterpillar Inc. jaise companies ke saath collaboration. Yeh dikhata hai ki kaise industry aur academia milkar kaam kar sakte hain.
Commercialization Struggles Kyun?
Innovation ko successful banane mein kuch badi challenges hain. India pehle research mein toh accha hai (Technology Readiness Levels 1-3), par use market-ready products (TRLs 7-9) mein badalne mein struggle karta hai. Yeh 'valley of death' academia aur industry ke weak links, limited technology transfer, aur cautious private sector ki wajah se hai. Private sector badi companies new R&D mein invest karne ke bajaye existing technologies license karna pasand karti hain. Red tape, slow approvals, aur rigid rules bhi research ko slow karte hain. Long-term R&D mein investment kam hai kyunki families aur pressure short-term profit ka hota hai. Private sector ka low R&D expenditure hi main problem hai, sirf paison ki kami nahi.
Aage Ka Raasta Kya Hai?
Government efforts jaise ₹1 lakh crore wala RDI Scheme aur Anusandhan National Research Foundation (ANRF) private sector-led innovation ko badhane aur commercialization ko speed up karne ke liye hain. Inka aim hai companies ke liye risk kam karna aur private R&D investment ko encourage karna. Par yeh tabhi successful honge jab deep-rooted structural issues solve honge. India ko R&D budgets badhane ke saath-saath risk-taking ko promote karne wale reforms, streamlined bureaucracy, better technology transfer, aur practical innovation ki culture banani hogi taaki research se lasting economic growth ho.
